Clinical trials: Trichotillomania
Trichotillomania (Hair-Pulling Disorder)
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
This trial aims to evaluate the efficacy, safety and tolerability of valbenazine, titrated to the subject's optimal dose of 40mg or 80mg, administered once daily, for 12 weeks, for the treatment of trichotillomania (TTM) in a…
- Trial name
- NCT05207085
- Testing
- Valbenazine Oral Capsule
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Yale University
Trichotillomania
Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania
This study will be the first randomized controlled trial of Comprehensive Behavior Modification (ComB) as a treatment of trichotillomania (TTM).
- Trial name
- NCT03486041
- Testing
- Comprehensive Behavior Modification, Attention
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- American University
Trichotillomania
Naltrexone in the Treatment of Trichotillomania
This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania
- Trial name
- NCT00775229
- Testing
- Naltrexone
- Where
- United States
- Volunteers
- 51 people
- Sponsor
- University of Chicago
Trichotillomania
Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
Trichotillomania (TTM) or hair-pulling has been considered as part of the obsessive compulsive disorder (OCD) spectrum, although treatment with OCD medications has largely been unsuccessful.
- Trial name
- NCT00182507
- Testing
- Olanzapine
- Where
- Canada
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Hamilton Health Sciences Corporation
Trichotillomania (Hair-Pulling Disorder), Trichotillomania
Semaglutide (Wegovy) Treatment for Trichotillomania
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
- Conditions
- Trichotillomania (Hair-Pulling Disorder), Trichotillomania, Hair Pulling Disorder, Hair Pulling
- Trial name
- NCT07282769
- Testing
- Semaglutide
- Volunteers
- 10 people
- Sponsor
- University of Chicago
Obsessive Compulsive Disorder
Genetics of Obsessive-Compulsive Disorder
The purpose of this study is to identify genes that affect susceptibility to obsessive-compulsive disorder (OCD). By identifying genes that increase or decrease the risk of OCD, researchers can better understand how the condition…
- Trial name
- NCT00001548
- Where
- United States
- Volunteers
- 1,067 people
- Sponsor
- National Institute of Mental Health (NIMH)
Trichotillomania
Cognitive Training in Patients With Trichotillomania (Hair-pulling Disorder)
The principal aim of this study is to establish the impact of Cognitive Training in patients with primary Hair-pulling Disorder.
- Trial name
- CTTTM (NCT02794753)
- Testing
- Working memory training, Game
- Where
- South Africa
- Volunteers
- 40 people
- Sponsor
- University of Stellenbosch
Obsessive-Compulsive Disorder, Tricholemmoma
Neural Mechanisms of Response Inhibition Training for OCRD
The impaired ability to suppress an inappropriate but pre-potent response (response inhibition; RI) characterizes several debilitating clinical problems, including obsessive-compulsive and related disorders (OCRD) such as…
- Conditions
- Obsessive-Compulsive Disorder, Tricholemmoma, Skin-Picking
- Trial name
- OCRD (NCT05377125)
- Testing
- Computerized cognitive training
- Where
- United States
- Volunteers
- 118 people
- Sponsor
- University of Wisconsin, Milwaukee
Impulse Control Disorders
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
The purpose of this study is to assess the extent of symptom remission in patients with trichotillomania following treatment with sertraline and/or behavior therapy.
- Trial name
- NCT00118014
- Testing
- Sertraline, Habit Reversal Training
- Where
- United States
- Volunteers
- 75 people
- Sponsor
- Massachusetts General Hospital